Welcome to the Bacteriophage Therapy Summit!
R&D
Have you been keeping up to date with phage advancements?
The recent $24 Million dedicated by BARDA to progress bacteriophage therapies to Phase II trials and the release of further regulatory guidelines by agencies suggest a new age of discovery.
The Bacteriophage Therapy Summit is returning to Boston for its 7th year with a curated room of industry players including Armata Pharmaceuticals, Phiogen Pharma, Kinzbio, and more!
From fresh perspectives into investment and regulatory challenges to efficacious clinical updates, this is a must-attend meeting to have on your 2025 radar!
Curious? Download the official brochure here: https://ter.li/ri8m6g
Don’t forget you can save up to 20% off when you register with your colleagues!
